Lapatinib and Bevacizumab for Metastatic Breast Cancer
Status: COMPLETED
Study type: INTERVENTIONAL
Conditions: Neoplasms, Breast
Interventions: DRUG: lapatinib|DRUG: bevacizumab
Sponsor: Novartis Pharmaceuticals